Small Molecule Generics to dominate in Egypt Generic Drugs Market through 2028

Egypt Generic Drugs Market is driven by the growing prevalence of diseases in Egypt during the forecast period, 2024-2028.

According to TechSci Research report, “Egypt Generic Drugs Market- Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Egypt Generic Drugs Market to grow at an impressive rate through 2028. This can be ascribed to the strong manufacturing capabilities of Egypt. Additionally, Egypt has a lower cost of manufacturing compared to many other countries, which makes it an attractive location for generic drug manufacturers. This allows companies to produce high-quality generic drugs at a lower cost, which benefits patients by making medications more affordable, thereby driving the growth of Egypt generic drugs markets. Furthermore, Egypt has a skilled workforce in the pharmaceutical industry, with many workers trained in the production of generic drugs. This allows local manufacturers to produce high-quality medications that meet international standards thereby supporting the growth of Egypt generic drugs market. Besides, many Egyptian generic drug manufacturers have formed partnerships with international companies to develop and manufacture generic drugs. These partnerships allow local manufacturers to benefit from international expertise, while also expanding their reach in the global market. This in turn is expected to support the growth of Egypt generic drugs market in the coming years.

There is a growing emphasis on the quality and safety of generic drugs in Egypt. Regulatory agencies are increasing their oversight of the industry, and manufacturers are investing in quality assurance systems to ensure that their products meet international standards. This in turn will make room for Egyptian manufactured generic drugs not only in the domestic market but also overseas, thereby opening new prospects for the overall growth of Egypt generic drugs market. Also, there is a growing interest in the development and manufacturing of biopharmaceuticals in Egypt, which are used to treat a range of diseases, including cancer and autoimmune disorders. This is a relatively new area for the local industry, but there is significant potential for growth in this market segment. The use of digital technology, such as telemedicine and e-pharmacies, is increasing in Egypt. This is creating new opportunities for the distribution and sale of generic drugs, as well as improving patient access to healthcare services.

However, competition of imported products can hamper the growth of Egypt generic drugs market. The Egyptian government has made efforts to encourage local manufacturing of generic drugs, imported drugs continue to be popular due to perceptions of higher quality and reliability. Also, many small and medium-sized generic drug manufacturers in Egypt face limited access to financing, which can make it difficult for them to invest in research and development and expand their operations, thereby slowing down the growth of Egypt generic drugs market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the "Egypt Generic Drugs Market”

Egypt Generic Drugs market is segmented into type, application, drug delivery, form, source, distribution channel, region, and company. In terms of drug delivery, Egypt Generic Drugs Market can be divided into oral, topical, parenteral, and others. The oral route dominated the Egypt generic drugs market in 2022 owing to the various benefits associated with oral route of drug delivery such as convenience, self and pain free administration, among others. Additionally, oral route of drug delivery is regarded as the simplest and safest means of drug administration.

By form, Egypt Generic Drugs Market can be fragmented into tablet, capsule, injection, and others. The tablet segment dominated the Egypt Generic Drugs market in 2022 and will continue maintaining its dominance through 2028 on account of the fact that they can accommodate a higher dose of active ingredient than other counterparts. Additionally, tablets have longer shelf life and are available in variety of forms.

Major companies operating in the Egypt Generic Drugs Market are:

• Eva Pharma
• Pharco Pharmaceuticals
• Amoun Pharmaceutical Company S.A.E. (“Amoun”)
• Rameda Pharmaceutical Company
• Delta Pharmaceutical Industries
• Global Napi Pharmaceuticals (Global Pharmaceutical Group)
• Minapharm Pharmaceuticals Co.
• Adwia Pharmaceuticals Co.
• GlaxoSmithKline S.A.E
• Sanofi Egypt
• Hikma Pharmaceuticals Plc
• Egyptian International Pharmaceutical Industries (EIPICO)
• Medical Union Pharmaceuticals
• MDI Pharma
• AstraZeneca Egypt

Download Sample Report

Customers can also request for 10% free customization on this report.

“In Egypt, generic drugs are widely available and play a significant role in the country's healthcare system. The government encourages the use of generic drugs to provide affordable and accessible healthcare to all citizens. This has led to an increase in the availability and use of generic drugs in the country, thereby driving the growth of Egypt generic drugs market. The Egypt generic drugs market is highly competitive, with several local and international companies operating in the space. In addition to the domestic market, Egypt is also an exporter of generic drugs. The country exports to several countries in the Middle East and Africa, with Saudi Arabia and Sudan being the largest markets.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

Egypt Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) By Region, Competition, Forecast & Opportunities, 2028F, has evaluated the future growth potential of Egypt Generic Drugs Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Egypt Generic Drugs Market.”

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com